San Antonio, Texas
CNS medication trials in San Antonio, TX
25 CNS medication studies are recruiting participants at sites in San Antonio as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
San Antonio at a glance
- 25 studies are recruiting at a site in San Antonio.
- By phase: Phase 1 (1), Phase 2 (2), Phase 3 (20), Phase 4 (2).
- By sponsor: industry (23), university, hospital or other (2).
- By research area: Parkinson's Disease (7), Migraine (6), Depression (4), Multiple Sclerosis (3), ADHD (2), Schizophrenia (2), Epilepsy (1).
- Most recent update to one of these records: November 17, 2026.
Depression studies recruiting in San Antonio
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Phase 3
- Ages 18 to 85
- All sexes
- Sponsor
- Cybin IRL Limited
- Study site
- Flourish Research San Antonio
- Registry record
- NCT06793397 · updated
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07484217 · updated
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Autobahn Therapeutics, Inc.
- Study site
- Autobahn Site #146
- Registry record
- NCT06633016 · updated
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Phase 4
- Ages 18 to 65
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT06223880 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in San Antonio, TX on ClinicalTrials.gov.
Schizophrenia studies recruiting in San Antonio
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases
- Registry record
- NCT06585787 · updated
Comparing Antipsychotic Medications in LBD Over Time
- Phase 4
- All ages
- All sexes
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Study sites
- UT Health Science Center - San Antonio · University Health System
- Registry record
- NCT05590637 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in San Antonio, TX on ClinicalTrials.gov.
ADHD studies recruiting in San Antonio
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717892 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in San Antonio, TX on ClinicalTrials.gov.
Parkinson's disease studies recruiting in San Antonio
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Texas Oncology - San Antonio ( Site 8001)
- Registry record
- NCT06841354 · updated
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Texas Oncology-San Antonio Medical Center ( Site 8001)
- Registry record
- NCT06952504 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Texas Oncology - San Antonio ( Site 8004)
- Registry record
- NCT06966700 · updated
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06989112 · updated
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
- Phase 2
- Ages 50 to 80
- All sexes
- Sponsor
- Yale University
- Study site
- University of Texas Health Science Center- San Antonio
- Registry record
- NCT06996652 · updated
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Texas Oncology - San Antonio ( Site 8002)
- Registry record
- NCT06312176 · updated
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT07161414 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in San Antonio, TX on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in San Antonio
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Study site
- Lone Star Neurology
- Registry record
- NCT07299019 · updated
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Study site
- Lone Star Neurology
- Registry record
- NCT07067463 · updated
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Sanofi
- Study site
- Neurology Center of San Antonio- Site Number : 8400099
- Registry record
- NCT07325292 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in San Antonio, TX on ClinicalTrials.gov.
Epilepsy studies recruiting in San Antonio
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- University of Texas Health Science Center at San Antonio
- Registry record
- NCT05667142 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in San Antonio, TX on ClinicalTrials.gov.
Migraine studies recruiting in San Antonio
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study sites
- Clinical Trials of Texas, LLC, A Flourish Research Site · San Antonio Clinical Trials
- Registry record
- NCT07816367 · updated
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- H. Lundbeck A/S
- Study site
- Road Runner Research (RRR)
- Registry record
- NCT04965675 · updated
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- DCT-Stone Oak, LLC dba Discovery Clinical Trials
- Registry record
- NCT05156398 · updated
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- H. Lundbeck A/S
- Study site
- Road Runner Research (RRR)
- Registry record
- NCT05164172 · updated
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- H. Lundbeck A/S
- Study site
- Road Runner Research (RRR)
- Registry record
- NCT05897320 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Road Runner Research /ID# 230527
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in San Antonio, TX on ClinicalTrials.gov.
Ask about studies near San Antonio
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
147 studies recruiting across 48 cities.
Houston
66 studies recruiting.
Austin
52 studies recruiting.
Dallas
36 studies recruiting.
Richardson
24 studies recruiting.
DeSoto
23 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections